期刊文献+

抗雌激素活性化合物及其构效关系研究 被引量:1

Studies on antiestrogen compounds and their structure-activity relationships
下载PDF
导出
摘要 抗雌激素疗法是雌激素受体依赖性乳腺癌内分泌疗法的重要手段之一。抗雌激素化合物按作用机制分类可分为选择性雌激素受体调节剂和纯抗雌激素剂,其结构类型主要包括取代雌二醇衍生物、三苯乙烯、苯骈杂环类及多酚类天然化合物。本文重点综述近年来抗雌激素化合物的作用机制、构效关系及其研究进展。 Antiestrogens have been proven to be highly effective in the treatment of estrogen receptor-dependent breast cancer.According to the mechanism,antiestrogen compounds were mainly categorized as selective estrogen receptor modulators(SERM)and pure antiestrogens,which structurally include estradiol derivatives,triphenylethylenes,benzo heterocyclic and polyphenol of natural compounds.The research advances on the antiestrogen compounds and their structure-activity relationships are reviewed.
出处 《国际药学研究杂志》 CAS 2010年第1期16-20,共5页 Journal of International Pharmaceutical Research
基金 国家自然科学基金资助项目(No.30770655)
关键词 雌激素受体 选择性雌激素受体调节剂 纯抗雌激素剂 构效关系 estrogen receptor selective estrogen receptor modulators pure antiestrogens structure-activity relationships
  • 相关文献

参考文献20

  • 1Henke BR, Heyer D. Recent advances in estrogen receptor modulators[J]. Curr Opin Drug Discov Devel , 2005, 8(4) :437 - 438.
  • 2冯长根,邓霞飞,向华,廖清江.治疗乳腺癌的抗雌激素药物研究进展[J].中国新药杂志,2006,15(13):1051-1057. 被引量:13
  • 3Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health[J]. Mol Aspects Med, 2006, 27 (4):299-402.
  • 4Dowsett M, Nicholson RI, Pietras RJ. Biological characteristics of the pure antiestrogen fulvestrant : overcoming endocrine [ J ]. Breast Cancer Res Treat, 2005, 93(Suppl 1 ) :S11 - S18.
  • 5Jordan VC. Tamoxifen (IC146,474) as a targeted therapy to treat and prevent breast cancer [J]. Br J Pharmacol, 2006, 147 ( Suppl 1 ) : S269 - S276.
  • 6Mansel R, Goyal A, Nestour EL, et al. A phase Ⅱ trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women [ J ]. Breast Cancer Res Treat, 2007, 106 (3) :389 - 397.
  • 7Goss PE, Qi SL, Hu HQ. Comparing the effects of atamestane,toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats[J]. J Steroid Biochem Mol Biol, 2009, 113(3) :233 -240.
  • 8Overk CR, Peng KW, Asghodom RT, et al. Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene [J]. Chem Med Chem, 2007, 2(10) :1520 - 1526.
  • 9Bolognese J, Krege WH, Utian WH, et al. Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass [J]. J Clin Endocrinol Metab, 2009, 94(7) :2284 -2289.
  • 10Al-Dhaheri MH, Shah YM, Basrur V, et al. Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells[J], Steroids, 2006, 71 ( 11/ 12) :966-978.

二级参考文献31

  • 1HENKE BR,HEVER D.Recent advances in estrogen receptor modulators[J].Curr Opin Drug Devel,2005,8(4):437-448.
  • 2ELKAK AE,MOKBEL K.Pure antiestrogens and breast cancer[J].Curr Med Res Opin,2001,17(4):282 -289.
  • 3YOUNUS J,VANDENBERG TA.A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer[J].Bull Cancer,2005,92 (4):E39-E44.
  • 4BUZDAR AU.Fulvestrant:a new type of estrogen receptor antagonist for the treatment of advanced breast cancer[J].Drugs Today,2004,40(9):751 -764.
  • 5BRUCE HM,COHEN FJ.Selective estrogen receptor modulators:alook ahead[J].Drugs,1999,57(5):653 -663.
  • 6BRZOZOWSKI AM,PIKE ACW,DAUTER Z,et al.Molecular basis of agonism and antagonism in the oestrogen receptor[J].Nature,1997,389(6652):753 -758.
  • 7DOWSETT M,NICHOLSON RI,PIETRAS RJ.Biological characteristics of the pure antiestrogen fulvestrant:overcoming endocrine resistance[J].Breast Cancer Res Treat,2005,93(Suppl1):S11-S18.
  • 8FISHER B,COSTANTINO JP,WICKERHAM DL,et al.Tamoxifen for prevention of breast cancer:report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study[J].J Natl Cancer Iust,1998,90(18):1371-1388.
  • 9FISHER B,DIGNAM J,BRYANT J,et al.Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors[J].J Natl Cancer Inst,1996,88(21):1529-1542.
  • 10CHOI SH,SHAPIRO H,ROBINSON GE,et al.Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin[J].J Psychosom Obstet Gynaecol,2005,26 (2):93-100.

共引文献13

同被引文献20

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部